← Back to Search

Investigational Liver Fat Quantification Software for Non-alcoholic Fatty Liver Disease (LFQ Trial)

N/A
Waitlist Available
Led By Anthony E. Samir, MD
Research Sponsored by Philips Clinical & Medical Affairs Global
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up intra-procedural (1 day)
Awards & highlights

LFQ Trial Summary

This trial will compare an experimental ultrasound technique for measuring liver fat against the current standard MRI procedure, in order to see if the ultrasound is a feasible option.

Eligible Conditions
  • Non-alcoholic Fatty Liver Disease (NAFLD)
  • Non-alcoholic Fatty Liver Disease

LFQ Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~intra-procedural (1 day)
This trial's timeline: 3 weeks for screening, Varies for treatment, and intra-procedural (1 day) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Correlation of the liver fat percentage reported from MRI-PDFF with measurements of ultrasound biomarkers for liver fat.
Secondary outcome measures
Inter-operator variability in measurements of ultrasound biomarkers for liver fat
Ultrasound biomarker measurement failure rate

LFQ Trial Design

1Treatment groups
Experimental Treatment
Group I: Investigational Ultrasound Imaging for Liver Fat QuantificationExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Investigational Liver Fat Quantification Software
2020
N/A
~100

Find a Location

Who is running the clinical trial?

Philips Clinical & Medical Affairs GlobalLead Sponsor
48 Previous Clinical Trials
15,915 Total Patients Enrolled
1 Trials studying Non-alcoholic Fatty Liver Disease
34 Patients Enrolled for Non-alcoholic Fatty Liver Disease
Anthony E. Samir, MDPrincipal InvestigatorMassachusetts General Hospital
2 Previous Clinical Trials
34 Total Patients Enrolled
Stephan Anderson, MDPrincipal InvestigatorBoston Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are enrolled in this medical trial?

"Affirmative, clinicaltrials.gov displays that this trial is actively scouting for participants. It was initially launched on October 30th 2020 and has had its parameters adjusted as recently as May 23rd 2022. Sixty individuals are being recruited across two medical sites."

Answered by AI

Are there any recruitment opportunities for this research endeavor?

"Clinicaltrials.gov reveals that this trial is actively seeking eligible patients; it was first posted on October 30th 2020 and modified most recently on May 23rd 2022."

Answered by AI

Who else is applying?

What state do they live in?
Massachusetts
Ohio
How old are they?
65+
18 - 65
What site did they apply to?
Boston Medical Center
Radiology Consultants, Inc
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Most responsive sites:
  1. Radiology Consultants, Inc: < 24 hours
Typically responds via
Email
Average response time
  • < 1 Day
~14 spots leftby Apr 2025